Skip to content

    Manorama Industries Q3 FY26 earnings call

    MANORAMA
    Fast Moving Consumer Goods·28 Jan 2026
    Management Summary

    Manorama Industries reported strong Q3 and 9M FY26 results, with revenue growing 81.3% YoY for 9M FY26 and an EBITDA margin of 27.2%. The company raised its FY26 revenue guidance to ₹1,300 crores and announced a significant ₹460 crores capex plan for new facilities and capacity expansion over the next 2-3 years. Management emphasized its technology-driven product strategy, which insulates it from commodity price volatility, and its focus on value-added products and internal accruals for funding growth.

    Highlights

    5
    • Revenue for 9M FY26 grew by 81.3% YoY to ₹975 crores, reflecting strong performance.

    • EBITDA margin for 9M FY26 stood at 27.2% and for Q3 FY26 at 27.1%, indicating robust profitability.

    • FY26 revenue guidance was revised upward from ₹1,150 crores to ₹1,300 crores, underscoring confidence in growth trajectory.

    • The company plans a ₹460 crores capex over 2-3 years for new facilities, including 75,000 MTPA for cocoa butter alternatives and 75,000 MTPA for fractionation.

    • Value-added products contribute around 75% to sales, with a target to increase to 85-90% going forward.

    Concerns

    2
    • Gross margins for Q3 FY26 were 44.3%, down from 52.8% in the previous quarter, attributed to freight costs and byproduct realization, though management states EBITDA/PAT margins are unaffected.

    • Working capital cycle for existing business is 5-6 months, though new projects are expected to have a shorter cycle of 1-3 months.

    Key financials

    Metrics

    10

    Periods

    2

    Q3 FY26

    5
    • Revenue
      ₹363 Cr
    • EBITDA
      ₹98 Cr
    • EBITDA Margin
      27.1%
    • PAT
      ₹68 Cr
    • PAT Margin
      18.8%

    9M FY26

    5
    • Revenue
      ₹975 Cr
      YoY+81.3%
    • EBITDA
      ₹265 Cr
    • EBITDA Margin
      27.2%
    • PAT
      ₹174 Cr
    • PAT Margin
      17.8%

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    ₹70 crores

    Primarily internal accruals, with ₹52 crores already spent. External financing considered selectively if necessary.

    M&A

    Dekel Group

    joint venture · integrated

    Liquidity

    Liquidity disclosed

    Internal cash accruals are very strong and sufficient to support planned projects.

    Guidance & targets

    7
    CategoryTargetPriority
    Revenue
    FY26 Revenue Guidance
    ₹1,300 crores
    High
    Capacity
    Existing Fractionation Capacity Expansion
    52,000 metric tons per annum
    High
    Asset Turnover
    Asset Turnover for New Capex
    more than 5x
    Medium
    Working Capital Cycle
    Working Capital Cycle for New Projects
    1-3 months
    High
    Product Mix
    Value-added Product Contribution to Sales
    85-90%
    Medium
    Growth
    Overall Growth (next year)
    30%+
    Medium
    Volume
    Mexico Plant Volume
    >2,000 tons
    Medium

    What to watch in Q4 FY26

    4

    Progress on ₹460 Cr Capex

    next quarter
    Current₹52 crores spent, ₹70-80 crores planned for FY26
    TargetFurther investment and progress on new facilities (CBA, fractionation, refinery, Burkina Faso)

    Why it matters

    Timely execution of the significant capex plan is crucial for future growth and capacity expansion, directly impacting revenue and market share targets.

    We plan to invest approximately INR 70 to 80 crores in this financial year to build capex. And in the next financial year, we are planning to spend around INR 100 to 150 crores towards our capex plan of the project.

    Risks & concerns

    2
    RiskSeverity

    Gross Margin Volatility

    Gross margins for Q3 FY26 were 44.3%, down from 52.8% in the previous quarter, attributed to fluctuations in freight costs and byproduct realization. Management states this is range-bound and does not impact EBITDA/PAT margins.Analyst acknowledged

    medium

    Commodity Price Volatility (Cocoa)

    Analysts raised concerns about falling cocoa prices. Management clarified that Manorama's products (CBEs) are technology and formulation-driven, not commodity-linked, and thus insulated from such price fluctuations, maintaining stable margins.Analyst downplayed

    low

    Q&A highlights

    7

    “So that particular capacity of fractionation will be used for making ESOS product and also the HPMF, which we're going to use and blend it with our existing stearin component and going forward ESOS component to make a better and value-enhanced product. So that particular fractionation capacity of 75,000 tons is with respect to the project of ESOS, which we have announced for 75,000 tons. So those both capacities are related to each other.”

    Clarified that the 75,000 MTPA fractionation capacity is specifically for new value-added products like ESOS and HPMF, not an addition to existing capacity, and is linked to the 75,000 MTPA CBA facility.

    asked by Jeevan P.

    3 min read6 chapters

    Detailed Narrative

    01

    Q3 & 9M FY26 Performance Overview

    Manorama Industries reported robust financial performance for Q3 and 9M FY26. For the nine months ended December 31, 2025, revenue stood at ₹975 crores, marking an impressive 81.3% year-on-year growth. EBITDA for the period was ₹265 crores, with a margin of 27.2%, and Profit After Tax (PAT) was ₹174 crores, translating to a 17.8% margin. For Q3 FY26 alone, revenue was ₹363 crores, EBITDA ₹98 crores (27.1% margin), and PAT ₹68 crores (18.8% margin). This growth was primarily volume-driven, with approximately 65% attributed to volume and the remainder to inflation and pricing.

    02

    Strategic Capacity Expansion & Capex Plans

    The company announced a significant capital expenditure plan of ₹460 crores over the next 2-3 years to address increasing demand. This includes boosting existing fractionation capacity by 30% to 52,000 metric tons per annum by FY26 through debottlenecking. New projects include a 75,000 MTPA manufacturing facility for cocoa butter alternatives (CBA), a 75,000 MTPA fractionation facility for exotic seeds (including ESOS), a 90,000 MTPA refinery, and a 90,000 MTPA processing factory in Burkina Faso, West Africa. Approximately ₹52 crores have already been invested, with ₹70-80 crores planned for FY26 and ₹100-150 crores for the next fiscal year, primarily funded through internal accruals.

    03

    Product Strategy & Margin Stability

    Manorama Industries emphasized its technology and formulation-driven business model, which focuses on specialized fat blending and fractionation for functional fats. This approach, coupled with strong R&D and deep sourcing networks, creates a defensible competitive moat and insulates the company from commodity price volatility, such as that seen in cocoa. Management stated that their EBITDA margins are sustainable in the 25-27% range, with a goal to improve them further. Value-added products currently constitute about 75% of sales, with a target to increase this to 85-90% going forward.

    04

    Working Capital Management

    The company's overall working capital cycle is currently around 120 days. However, for the new forward integration projects, the working capital cycle is expected to be significantly shorter, ranging from 1 to 3 months, compared to the existing business model's 5-6 months. This is due to the different raw material sourcing and captive consumption strategies for these new products. Management expects the overall working capital cycle to reduce by 10-20 days with the new capacity coming online.

    05

    International Expansion & Partnerships

    Manorama Industries is expanding its global footprint, with plans to enhance capacities in both India and West Africa. The company has started batches and is in the process of ramping up its partnership with the Dekel Group in Brazil, which is expected to provide minor revenue contributions in the current quarter. This partnership aims to leverage a geographical presence in the LatAm market, which is a significant consumption hub, to cater to a broader customer base beyond the top-tier clients.

    06

    Outlook and Growth Drivers

    The company revised its FY26 revenue guidance upward from ₹1,150 crores to ₹1,300 crores, reflecting confidence in its growth trajectory. The planned capacity expansions, including the 30% increase in existing capacity and the new facilities, are expected to drive growth for the next 4-5 years. Management anticipates an asset turnover of more than 5x from the new capex. The focus on value-added products, operational excellence, and backward integration are key pillars for sustainable growth and maintaining leadership in specialty fats and butters.

    This is an AI-generated summary of a publicly available earnings call transcript.